[
    {
        "outcome_uid": "9a3ef06c",
        "clinical_question": "Should patients with RA initiating MTX receive oral MTX or subcutaneous (SC) MTX?",
        "population": "Patients with RA initiating MTX",
        "intervention": "Oral MTX",
        "comparator": "SC MTX",
        "outcome": "Disease Activity (follow up: 4 months; assessed with: ACR 20)",
        "importance": "CRITICAL",
        "related_paper_list": [
            "5efdfbb8"
        ],
        "assessment_results": {
            "GRADE": {
                "Risk of bias": {
                    "result": "NOT_SERIOUS",
                    "rationales": "The study did not report on whether allocation was concealed."
                },
                "Inconsistency": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Indirectness": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Imprecision": {
                    "result": "SERIOUS",
                    "rationales": "Downgraded by one level due to serious imprecision. Confidence intervals includes both values suggesting no effect and values suggesting benefit."
                },
                "Other considerations": {
                    "result": "none",
                    "rationales": ""
                },
                "Study design": "Randomized Controlled Trial",
                "Certainty": "MODERATE",
                "No of participants": {
                    "SC MTX": "160/188 (85.1%)",
                    "Oral MTX": "144/187 (77.0%)"
                },
                "Annotation": {},
                "Effect": {
                    "Relative Effect (95% CI)": "RR 1.11 (1.00 to 1.22)",
                    "Absolute Effect (95% CI)": "85 more per 1,000 (from 0 fewer to 169 more)",
                    "Abbreviations": "CI: Confidence interval; RR: Risk ratio; MD: Mean difference; HR: Hazard Ratio"
                }
            }
        }
    }
]